251 related articles for article (PubMed ID: 10965460)
1. Adenocarcinoma of the prostate with ectopic antidiuretic hormone production: a case report.
Ito H; Nishimura T; Abe H; Oka F; Miura T; Uchikoba T; Oaki Y
Hinyokika Kiyo; 2000 Jul; 46(7):499-503. PubMed ID: 10965460
[TBL] [Abstract][Full Text] [Related]
2. Syndrome of inappropriate antidiuretic hormone secretion in a patient with hormone refractory prostate cancer.
Bogdanos J; Karamanolakis D; Milathianakis C; Koutsilieris M
Anticancer Res; 2003; 23(2C):1755-6. PubMed ID: 12820453
[TBL] [Abstract][Full Text] [Related]
3. Cushing syndrome associated with prostatic tumor adrenocorticotropic hormone (ACTH) expression after maximal androgen blockade therapy.
Kataoka K; Akasaka Y; Nakajima K; Nagao K; Hara H; Miura K; Ishii N
Int J Urol; 2007 May; 14(5):436-9. PubMed ID: 17511728
[TBL] [Abstract][Full Text] [Related]
4. [Inappropriate antidiuretic hormone secretion syndrome: a rare manifestation of prostatic adenocarcinoma].
Pereira Arias JG; Astobieta Odriozola A; Prieto Ugidos N; Aurtenetxe Goiriena JJ; Bernuy Malfaz C
Arch Esp Urol; 1995 Dec; 48(10):1042-5. PubMed ID: 8588724
[TBL] [Abstract][Full Text] [Related]
5. Effects of flutamide as a second-line agent for maximum androgen blockade of hormone refractory prostate cancer.
Nishimura K; Arichi N; Tokugawa S; Yoshioka I; Kishikawa H; Ichikawa Y
Int J Urol; 2007 Mar; 14(3):264-7. PubMed ID: 17430272
[TBL] [Abstract][Full Text] [Related]
6. Alternative nonsteroidal antiandrogen therapy for advanced prostate cancer that relapsed after initial maximum androgen blockade.
Suzuki H; Okihara K; Miyake H; Fujisawa M; Miyoshi S; Matsumoto T; Fujii M; Takihana Y; Usui T; Matsuda T; Ozono S; Kumon H; Ichikawa T; Miki T;
J Urol; 2008 Sep; 180(3):921-7. PubMed ID: 18635218
[TBL] [Abstract][Full Text] [Related]
7. The effects of combined androgen blockade on cognitive function during the first cycle of intermittent androgen suppression in patients with prostate cancer.
Cherrier MM; Rose AL; Higano C
J Urol; 2003 Nov; 170(5):1808-11. PubMed ID: 14532781
[TBL] [Abstract][Full Text] [Related]
8. The syndrome of inappropriate antidiuretic hormone secretion in a patient with adenocarcinoma of the prostate.
Gasparini ME; Broderick GA; Narayan P
J Urol; 1993 Sep; 150(3):978-80. PubMed ID: 8345625
[TBL] [Abstract][Full Text] [Related]
9. [A case of adenocarcinoma of the nasal cavity associated with syndrome of inappropriate secretion of antidiuretic hormone(SIADH)].
Tatemoto K; Goto K; Uno T; Yoshimatu M; Ono T; Hisa Y; Tachibana M; Ohtsuki T; Tohno-oka A
Gan No Rinsho; 1989 Sep; 35(10):1153-9. PubMed ID: 2778960
[TBL] [Abstract][Full Text] [Related]
10. Syndrome of inappropriate antidiuretic hormone secretion: a rare complication of prostate cancer.
Garzotto M; Beer TM
J Urol; 2001 Oct; 166(4):1386. PubMed ID: 11547083
[No Abstract] [Full Text] [Related]
11. Clinical outcome of maximum androgen blockade using flutamide as second-line hormonal therapy for hormone-refractory prostate cancer.
Miyake H; Hara I; Eto H
BJU Int; 2005 Oct; 96(6):791-5. PubMed ID: 16153202
[TBL] [Abstract][Full Text] [Related]
12. Radical prostatectomy and adjuvant endocrine therapy for prostate cancer with or without preoperative androgen deprivation: Five-year results.
Homma Y; Akaza H; Okada K; Yokoyama M; Moriyama N; Usami M; Hirao Y; Tsushima T; Sakamoto A; Ohashi Y; Aso Y;
Int J Urol; 2004 May; 11(5):295-303. PubMed ID: 15147545
[TBL] [Abstract][Full Text] [Related]
13. [Hepatic encephalopathy induced by flutamide administered for the treatment of prostatic cancer].
Patel H; Rhee E; Zimmern PE
J Urol (Paris); 1996; 102(3):123-5. PubMed ID: 9091557
[TBL] [Abstract][Full Text] [Related]
14. [Neuroendocrine differentiation in adenocarcinoma of the prostate during hormonal treatment : a case report].
Segawa N; Inamoto T; Ibuki N; Mizutani Y; Azuma H; Tsuji M; Katsuoka Y
Hinyokika Kiyo; 2010 Jan; 56(1):49-54. PubMed ID: 20104011
[TBL] [Abstract][Full Text] [Related]
15. Prostate adenocarcinoma producing syndrome of inappropriate secretion of antidiuretic hormone.
Yamazaki T; Suzuki H; Tobe T; Sekita N; Kito H; Ichikawa T; Akakura K; Igarashi T; Ito H
Int J Urol; 2001 Sep; 8(9):513-6. PubMed ID: 11683974
[TBL] [Abstract][Full Text] [Related]
16. [Prostate carcinoma and syndrome of inappropriate antidiuretic hormone secretion].
Miretti VS; Ávila RA; Sierra JT; García JJ; Laborié MV
Medicina (B Aires); 2018; 78(4):290-293. PubMed ID: 30125258
[TBL] [Abstract][Full Text] [Related]
17. A rare case of metastatic ductal type prostate adenocarcinoma presenting with syndrome of inappropriate secretion of antidiuretic hormone: a case report and review.
Shaaban H; Thomas D; Guron G
J Cancer Res Ther; 2012; 8(2):308-10. PubMed ID: 22842384
[TBL] [Abstract][Full Text] [Related]
18. [Luteinizing hormone-releasing hormone for prostate cancer in a hemodialysis patient: a case report].
Mizusawa H; Kontani K; Okaneya T; Yoneyama T
Hinyokika Kiyo; 1997 Jun; 43(6):421-3. PubMed ID: 9250492
[TBL] [Abstract][Full Text] [Related]
19. Intermittent androgen suppression for locally advanced and metastatic prostate cancer: preliminary report of a prospective multicenter study.
Sato N; Akakura K; Isaka S; Nakatsu H; Tanaka M; Ito H; Masai M;
Urology; 2004 Aug; 64(2):341-5. PubMed ID: 15302491
[TBL] [Abstract][Full Text] [Related]
20. Phase I-II trial evaluating combined intensity-modulated radiotherapy and in situ gene therapy with or without hormonal therapy in treatment of prostate cancer-interim report on PSA response and biopsy data.
Teh BS; Ayala G; Aguilar L; Mai WY; Timme TL; Vlachaki MT; Miles B; Kadmon D; Wheeler T; Caillouet J; Davis M; Carpenter LS; Lu HH; Chiu JK; Woo SY; Thompson T; Aguilar-Cordova E; Butler EB
Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1520-9. PubMed ID: 15050332
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
